Related Experiment Videos
TGF-beta 1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy
1Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Abstract:
The role of transforming growth factor-beta 1 (TGF-beta 1) for renal injury was investigated in the chronic model of progressive renal disease in rats induced by the injection of adriamycin. The renal cortical tissues were sampled at weeks 4, 8 and 16 for histological examination, either cortical or glomerular cell culture, and RNA extraction. A progressive increase in fibronectin synthesis was found in metabolically labeled cortical or glomerular culture at week 8 or 16, correlating with the degree of glomerulosclerosis and interstitial fibrosis. TGF-beta bioassay (mink lung epithelial cell assay) showed a progressive increase in latent TGF-beta secretion from cortex and glomeruli, while the amount of active TGF-beta was small. The peak of latent TGF-beta levels at week 16 coincided with the intense TGF-beta 1 staining of inflammatory cells dispersed in the interstitium and glomeruli. Northern blotting demonstrated the difference in the mRNA expression patterns of TGF-beta 1 and latent TGF-beta 1 binding protein (LTBP) in the cortex. TGF-beta 1 mRNA was constantly high throughout the experiment, while LTBP mRNA increased progressively and reached a peak at week 16. Furthermore, mRNA levels of fibronectin, procollagen alpha 2(I), and TGF-beta type II and type III receptors increased progressively in a similar pattern to the renal histological changes. These temporal and spacial relationships between the renal histological changes and the increased expression of TGF-beta 1 and TGF-beta receptors may thus suggest that TGF-beta 1 plays an important role in the process of the renal fibrosis and sclerosis.
Insights
Transforming growth factor-beta 1 (TGF-beta 1) is crucial in progressive renal disease, driving fibrosis and sclerosis. Increased TGF-beta 1 expression correlates with kidney damage in rats, highlighting its role in disease progression.
Area of Science:
- Nephrology
- Molecular Biology
- Pathology
Background:
- Adriamycin-induced nephropathy serves as a model for chronic progressive renal disease.
- Transforming growth factor-beta 1 (TGF-beta 1) is implicated in renal fibrosis.
Purpose of the Study:
- To investigate the role of TGF-beta 1 in adriamycin-induced progressive renal disease in rats.
- To correlate TGF-beta 1 expression with histological changes and fibrotic markers.
Main Methods:
- Rats were injected with adriamycin to induce chronic renal disease.
- Renal tissues were analyzed histologically, via cell culture, and RNA extraction at 4, 8, and 16 weeks.
- TGF-beta bioassays and Northern blotting were used to assess TGF-beta 1 and related gene expression.
Main Results:
- Progressive increases in fibronectin synthesis, glomerulosclerosis, and interstitial fibrosis were observed.
- Latent TGF-beta 1 secretion increased, peaking at week 16, coinciding with inflammatory cell staining.
- mRNA levels of TGF-beta 1, latent TGF-beta 1 binding protein (LTBP), fibronectin, procollagen alpha 2(I), and TGF-beta receptors showed progressive increases.
Conclusions:
- TGF-beta 1 expression and its receptors are upregulated during progressive renal disease.
- The temporal and spatial correlation suggests a significant role for TGF-beta 1 in renal fibrosis and sclerosis.